• Human APIs PowderRespiratory Drugs Raw Material Antiviral Antibacterial Antipyretic Analgesics Antihistamine Drugs Antineoplastic Cosmetic Raw Material
  • Pharmaceutical IntermediatesPharmaceutical intermediates Nutritional Supplements Pharmaceutical raw materials
  • OEM & ODMCapsule Softgel Capsule Gummies Drop & drinks Tables
  • Veterinary raw materialsAntibacterial anti-inflammatory Respiratory Drugs Anthelmintics Antiviral drugs Feed additives
  • About UsCompany profileQualificationQuality AssuranceService teamFactory TourR&D Center
  • Nootropic raw Materials powder Nefiracetam

    • Nootropic raw Materials powder Nefiracetam
    • Nootropic raw Materials powder Nefiracetam storehouse
    • Nootropic raw Materials powder Nefiracetam quality testing
    • Nootropic raw Materials powder Nefiracetam quality testing
    • Nootropic raw Materials powder Nefiracetam certificate

    Product Overview:

    Nefeacetam belongs to the class of non-borderline intelligence enhancing drugs, which have different chemical structures and enhance cognitive ability and prevent learning and memory impairment through their effects on the cerebral cortex. It does not have the properties of muscarinic receptor agonists and antagonists, nor does it inhibit the activity of Ach, the anti-forgetting and memory-enhancing effects of this drug are achieved by enhancing the release of Ach in the cerebral cortex. Camp-dependent protein kinases enhance Ca2+ channel activity, which may be the reason why they enhance Ach release

    Nootropic raw Materials powder Nefiracetam Attributes

    Nefiracetam Raw Materials powder

    CAS:77191-36-7

    MF:C14H18N2O2

    Nefiracetam

    MW:246.3

    EINECS:636-080-4

    Specification: 99% min Nefiracetam powder

    Sample:Nefiracetam powder

    Packaging:1kg/bag, 25kg/drum

    Brand:Henrikang

    Appearance:white

    Storage: Cool Dry Place

    Shelf Life: 2 Years

    Test Method: HPLC

    Nootropic raw Materials powder Nefiracetam Details

    Nefiracetam powder Usage and Synthesis.

    Nefacetam, a cognitive enhancer in the Racetam family, was originally derived from the parent molecule piracetam, but is most structurally similar to aniracetam. Because Nefeacetam and aniracetam are fat-soluble drugs. They are used to improve the treatment of memory and cognitive impairment. The mechanism of action is nefeacetam in two so-called ways. The first is to lengthen the opening of calcium channels (which bind to PKA and Gi/o proteins) that enhance the receptor response, regardless of the synapse; A second pathway is associated with PKC and CAMKII, which then complete the response due to cholinergic receptors (which are then the most excited neurotransmitters released at the presynaptic level, as is the case with nicotine). The former pathway (calcium channel) is important in the long run, while the latter pathway (PKC/CAMKII) has an effect on the strengthening of nerve signals and their transmission. Some other minor ways can be partial agonists of the NDMA receptor that binds to glycine (which can enhance the interaction of certain levels of glycine and thus weaken the interaction), as well as increase its communication with the ligand acetylcholine acetylcholine receptor.

    Nefiracetam powder

    Uses of Nefiracetam.

    Nefacetam is used to treat cerebrovascular disease. It can enhance cognitive ability and prevent the damage of learning and memory through its effect on the cerebral cortex. It does not have the characteristics of muscarinic receptor agonist and antagonist, nor does it inhibit the activity of acetylcholinase. Therefore, its anti-forgetting and memory-enhancing effects are caused by increasing the release of acetylcholine in the cerebral cortex.

    Nefiracetam

    Pharmacological action of Nefiracetam.

    Product Methods of Nefiracetam.

    Our advantage
    Our Factory
    Shipping
    Tel: 86-29-89601602
    WhatsApp: 8615091775531
    WeChat: 15091775531
    E-mail: sales21@interlgroup.com
    Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
    ©2023 Xi'an Henrikang Biotech Co., Ltd.,